Clinical Trial Update: Neuroimaging of Escitalopram in Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial assessing neuroimaging measures for escitalopram in autism spectrum disorder; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Kathryn Unruh | Conditions: Autism Spectrum Disorder | Phase 2 | Status: ENROLLING_BY_INVITATION